Two human monoclonal SARS-CoV-2 antibodies that maintain neutralizing potency against the SARS-CoV-2 Omicron BA.1 and BA.2 variants.

ABSTRACT:

SUBMITTER: Zheng Q 

PROVIDER: S-EPMC9170589 | biostudies-literature | 2023 May

REPOSITORIES: biostudies-literature